Btk inhibitors in atherosclerosis

Btk inhibitors in atherosclerosis

In this issue of Blood , Busygina et al provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques. 1

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2018-06, Vol.131 (24), p.2601-2602
1. Verfasser: Lindner, Jonathan R.
Format: Artikel
Sprache:eng
Schlagworte:
Agammaglobulinaemia Tyrosine Kinase
Atherosclerosis
Humans
Plaque, Atherosclerotic
Protein Kinase Inhibitors
Thrombosis
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In this issue of Blood , Busygina et al provide provocative evidence that there is a potential role for Bruton tyrosine kinase (Btk) inhibitors in inhibiting platelet aggregation specifically at the site of unstable atherosclerotic plaques. 1
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2018-04-841916